UZ Leuven — Leuven, Belgium

Public research footprint of UZ Leuven, compiled from the ClinicalTrials.gov public registry.

1,650

Registered studies

587

Active

342

Recruiting now

758

Completed

188

Stopped or withdrawn

Most-studied conditions

Myotonic Dystrophy Type 1 (DM1) · Neovascular Age-related Macular Degeneration (nAMD) · Ischemic Stroke; Ischemic Attack, Transient · Cerebral Visual Impairment

Recently updated registry entries

NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT07015983 — A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in… (Active Not Recruiting)
NCT07741500 — Body Image, Identity Development, and Social Media Use Among Youth With Visual… (Not Yet Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UZ Leuven?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.